Vanta Bioscience

Name

Vanta Bioscience

Legal name

Vanta Bioscience Limited

Website

https://vantabio.com

Company type

Public

Founded year

2017

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Preclinical Contract Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)

akta.pro secondary industries

Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB), Laboratory Quality & GLP/GCLP Compliance (HLAGAKAK), Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH)

Keywords

• Preclinical contract research
• GLP toxicology services
• Safety assessment studies
• Biocompatibility testing
• Regulatory toxicology

Headquarters

HQ city

Gummidipundi

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Contract Research Services (Fee-for-Service): Vanta Bioscience generates revenue through fee-for-service preclinical contract research engagements. Services are quoted and priced based on study complexity, duration, and regulatory requirements. The company offers GLP-certified toxicology studies for pharmaceuticals, agrochemicals, chemicals, medical devices, cosmetics, and food additives. Revenue streams include single studies, multi-study programs, and strategic partnership arrangements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Vanta Bioscience is a full-service GLP-certified preclinical contract research organization (CRO) offering toxicology and safety assessment services for pharmaceutical, agrochemical, chemical, medical device, cosmetics, and food additive industries. Its core offerings include Discovery Toxicology (IND/NDA enabling studies), Agro-chemical and Chemical Safety (REACH compliance), Biocompatibility Studies (ISO 10993), Diet Formulation, and Batch Release Testing, all delivered from a 56,000 sq. ft. AAALAC and OECD GLP compliant facility in Chennai, India.

Product overview

Vanta Bioscience is a full service GLP certified preclinical contract research organization (CRO) offering a comprehensive portfolio of toxicology and safety assessment services. The company operates Discovery Toxicology as its primary service platform providing IND/NDA enabling safety studies, complemented by specialized services including Agro-chemicals and Chemical Safety (REACH compliance), Biocompatibility Studies (ISO 10993 for medical devices), Diet Formulation (DBT guidelines), and Batch Release Test (pharmacopoeia standards). Services are organized by industry verticals covering Pharmaceuticals, Agrochemicals & Chemicals, Medical Devices, Food Additives, and Cosmetics & Alternative Toxicological Methods. The company operates from a 56,000 sq. ft. AAALAC and GLP compliant research facility in Chennai, India.

Differentiator

Problem solved

Functional benefit

Products and services

• Discovery Toxicology Preclinical contract research services providing IND/NDA enabling safety studies including repeat exposure studies in rodents and non-rodents, developmental and reproductive toxicology, genotoxicity testing, drug metabolism, and pharmacokinetics for pharmaceutical and biopharmaceutical companies.
• Agro-chemicals and Chemical Safety End-to-end regulatory testing services for registration of agrochemicals and chemicals in compliance with OECD and international regulatory guidelines, including physico-chemical testing, acute studies, sub-acute to chronic studies, DART, and REACH compliance, for agrochemical and chemical industry clients.
• Biocompatibility Studies Biocompatibility testing services for medical devices according to ISO 10993 guidelines and US FDA modified ISO study matrix, covering cytotoxicity, sensitization, irritation, and implantation tests for medical device manufacturers.
• Diet Formulation Diet formulation services enabling conduct of toxicity studies per Department of Biotechnology, Government of India guidelines, including proximate analysis, diet balancing, irradiation, and packaging for biotechnology and pharmaceutical clients.
• Batch Release Test Pharmacopoeial batch release testing services including pyrogen testing, stability studies, abnormal toxicity, and impurity profiling as per USP, BP, and IP standards for pharmaceutical quality control clients.

Quantifiable outcome

• Data generated is recognized by OECD member countries including Canada, Germany, Japan, and U.S.
• +1 more outcomes

Named customers7 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Eight partnerships are on record, tiered minor and core.

• Coromandel International LimitedminorStrategic or Co-development Partner · 1 December 2022Vanta Bioscience received an order from Coromandel International Limited, a major agrochemical company. The order value was noted in corporate announcements filed with the stock exchange.
• Vayam ResearchcoreStrategic or Co-development Partner · 1 July 2019Vayam Research signed a CRO Service Agreement worth Rs. 29 Crores with Vanta Bioscience. Vayam Research Solutions Limited was a step-down subsidiary of Vanta Bioscience that ceased to be a subsidiary, indicating a strategic business relationship in the CRO services space.
• Bio-RadcoreTechnology or Integration · 1 January 2012Vanta Bioscience has been certified under Bio-Rad External Quality Assurance Services (EQAS) programs since 2012. Under this program, specimen packs and documentation are compared with results from other laboratories using the same methodologies, instruments, and reagents, ensuring quality control and reliability of testing results.
• Aurobindo PharmaminorStrategic or Co-development PartnerVanta Bioscience is part of the Aurobindo Group ecosystem. The website mentions Aurobindo as a strategic alliance partner, with Aurobindo having evolved into a knowledge-driven organization with over 24 years of experience.
• ABLE (Association of Biotechnology Led Enterprises)minorOthersVanta Bioscience is a member of ABLE, a not-for-profit pan-India forum representing the Indian Biotechnology Sector. ABLE has members from all across India representing all verticals of the sector including agribiotech, bio-pharma, industrial biotech, and bioinformatics.
• BCIL (Biotechnology Consortium of India Limited)minorOthersVanta Bioscience is a member of BCIL, a public limited company promoted by the Department of Biotechnology, Government of India, involved in technology transfer, project consultancy, fund syndication, and manpower training related to biotechnology.
• ASIO-SOT (Association of Scientists of Indian Origin - Society of Toxicology)minorOthersVanta Bioscience is a member of ASIO-SOT, a branch of National Association of Scientists of Indian Origin in America that promotes fellowship among scientists of Indian origin and establishes open channels of communication among all scientists.
• AI-MED (Association of Indian Manufacturers of Medical Devices)minorOthersVanta Bioscience is a member of AI-MED, an Umbrella Association of Indian Manufacturers of Medical Devices covering all types of Medical Devices including consumables, disposables, equipment and diagnostics, representing over 700 manufacturers.

Scale indicators11 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Syngene International: India-based preclinical and clinical CRO offering toxicology, DMPK, and safety assessment services. Direct comparability: fellow Indian GLP toxicology CRO serving global pharma/biotech sponsors with similar cost-arbitrage value proposition and AAALAC/GLP-compliant infrastructure.
• Sai Life Sciences: India-based contract research and development organization offering preclinical toxicology and safety pharmacology services. Comparable as a fellow Indian GLP toxicology CRO with global sponsor reach, OECD GLP-accredited facilities, and similar pharma/biopharma customer focus.
• Aragen Life Sciences (formerly GVK Biosciences): India-headquartered CRO providing preclinical toxicology and safety assessment alongside discovery and development services. Closely comparable: similar Indian-based GLP toxicology platform, pharma/biotech customer base, and AAALAC-accredited vivarium operating model.
• Piramal Pharma Solutions: India-based contract development and manufacturing organization with preclinical and safety assessment service lines. Comparable as a fellow Indian CRO offering GLP-compliant toxicology alongside broader development services to global pharmaceutical clients.
• Inotiv: U.S.-based contract research organization with core competency in preclinical toxicology, safety assessment, and animal model services. Directly comparable to Vanta as a pure-play GLP toxicology CRO serving medical device, pharma, and chemical industry clients.

Broad incumbents

• Charles River Laboratories: Global leader in preclinical CRO services including toxicology, safety pharmacology, and DMPK. Broad incumbent comparability: Vanta operates in Charles River's core Safety Assessment segment, mirroring the same GLP toxicology service portfolio for biopharma sponsors at materially smaller scale.
• WuXi AppTec (WuXi Xuying / WuXi Biology): Large-scale China-based global CRO with substantial preclinical toxicology and safety assessment capabilities. Relevant as a major Asia-headquartered preclinical CRO competitor serving the same global pharma/biotech outsourcing demand that Vanta targets.
• Eurofins Scientific: Global testing services platform with regulatory toxicology, agrochemical, REACH, and cosmetics testing service lines. Comparable as a broader testing/CRO incumbent offering overlapping GLP toxicology and regulatory safety study services across multiple verticals Vanta serves.
• Labcorp (Covance Drug Development): Global clinical and preclinical CRO providing toxicology, safety assessment, and central laboratory services through its Early Development segment. Broad incumbent comparability: overlapping GLP toxicology service portfolio for pharma/biopharma sponsors with materially greater global scale.

Emerging players

• Toxys (formerly part of TNO): Specialized toxicology CRO offering genotoxicity, developmental toxicology, and in vitro safety testing services. Comparable niche player focused on toxicology endpoints where Vanta's genotoxicity battery and DART services overlap.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/vanta-bioscience
• Xx.com/vantabio

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vanta Bioscience